Glenmede Trust’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,854
| Closed | -$33K | – | 2433 |
|
|
2020
Q3 | $33K | Buy |
2,854
+169
| +6% | +$1.95K | ﹤0.01% | 1439 |
|
|
2020
Q2 | $39K | Sell |
2,685
-1,339
| -33% | -$19.4K | ﹤0.01% | 1378 |
|
|
2020
Q1 | $97K | Hold |
4,024
| – | – | ﹤0.01% | 1431 |
|
|
2019
Q4 | $97K | Buy |
4,024
+528
| +15% | +$12.7K | ﹤0.01% | 1431 |
|
|
2019
Q3 | $67 | Buy |
3,496
+736
| +27% | +$14 | ﹤0.01% | 1542 |
|
|
2019
Q2 | $81 | Sell |
2,760
-2,420
| -47% | -$71 | ﹤0.01% | 1480 |
|
|
2019
Q1 | $246 | Buy |
5,180
+1,605
| +45% | +$76 | ﹤0.01% | 1105 |
|
|
2018
Q4 | $128 | Sell |
3,575
-2,088
| -37% | -$75 | ﹤0.01% | 1283 |
|
|
2018
Q3 | $348K | Buy |
5,663
+1,787
| +46% | +$110K | ﹤0.01% | 981 |
|
|
2018
Q2 | $262K | Buy |
3,876
+3,162
| +443% | +$214K | ﹤0.01% | 989 |
|
|
2018
Q1 | $42K | Hold |
714
| – | – | ﹤0.01% | 1700 |
|
|
2017
Q4 | $42K | Buy |
+714
| New | +$42K | ﹤0.01% | 1700 |
|